Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Blueprint Patient-Specific Instrumentation

K-Number: K253674 · 2026-04-03

Decision Date2026-04-03
Product CodePHX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Blueprint Patient-Specific Instrumentation is a medical device manufactured by Stryker Corporation (Tornier, S.A.S.). It received FDA 510(k) clearance on 2026-04-03 under approval number K253674. The device is classified under product code PHX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Blueprint Patient-Specific Instrumentation?

Blueprint Patient-Specific Instrumentation is a medical device that received FDA 510(k) clearance on 2026-04-03. It is manufactured by Stryker Corporation (Tornier, S.A.S.). The 510(k) number is K253674.

When was Blueprint Patient-Specific Instrumentation approved by the FDA?

Blueprint Patient-Specific Instrumentation received FDA 510(k) clearance on 2026-04-03, under approval number K253674.

What company makes Blueprint Patient-Specific Instrumentation?

Blueprint Patient-Specific Instrumentation is manufactured by Stryker Corporation (Tornier, S.A.S.).

What is the FDA product code for Blueprint Patient-Specific Instrumentation?

The FDA product code for Blueprint Patient-Specific Instrumentation is PHX.

Related Clinical Trials

Related PubMed Literature

Other Devices by Stryker Corporation (Tornier, S.A.S.)

Related Devices (Code: PHX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.